News

TipRanks on MSN6h
Klotho Neurosciences Receives FDA Orphan Drug Designation
Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...
Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble?
Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.
Klotho Neurosciences stock soars after FDA grants orphan drug status for ALS
Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...
US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus
U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...
InvestorsHub on MSN14h
Klotho Neurosciences Shares Jump as FDA Grants Orphan Drug Status for ALS Therapy
Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...
Investing9h
Klotho Neuroscience Inc News (KLTO) - Investing.com
Klotho Neurosciences Files $100M Mixed Shelf Klotho Neurosciences (KLTO) has filed $100,000,000 mixed shelf of: Common Stock Preferred Stock Warrants Units By Investing.com • Jul 07, 2025 ...
Explore more